NCT01050530View on ClinicalTrials.gov

A Trial to Investigate the Efficacy of OPC-41061 Administered at a Dose of 7.5 mg in Patients With Hepatic Edema

PHASE3CompletedINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Cirrhosis
Interventions
DRUG

OPC-41061

Once-daily oral administration of OPC-41061 at 7.5 mg after breakfast for 7 days

DRUG

Placebo

Once-daily oral administration of placebo after breakfast for 7 days

Trial Locations (8)

Unknown

Chubu Region

Chugoku Region

Hokkaido Region

Kanto Region

Kinki Region

Kyushu Region

Shikoku Region

Tohoku Region

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY